Vascugen, Inc. — Form D
Vascugen, Inc. of MADISON, WI, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-24. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-24
- Form: D
- Accession: 0001822206-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 6
- Date of first sale: 2019-10-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-373891
Issuer
- Name: Vascugen, Inc.
- CIK: 0001822206
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5602 RESEARCH PARK BLVD., MADISON, WI, 53719
- Phone: 6085145564
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Carter Cliff | Director | Cambridge, MA |
| Jeffrey Kennedy | Director | Madison, WI |
| Tom Novak | Director | Madison, WI |
| Marvin Yoder | Director | Madison, WI |
| Carter Cliff | Executive Officer | Cambridge, MA |
More